UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comment on: “Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs”

Drugs (New York, N.Y.), 2020-07, Vol.80 (11), p.1139-1140

2020

Volltextzugriff (PDF)

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

Schizophrenia research, 2007-02, Vol.90 (1), p.147-161

2007

Volltextzugriff (PDF)

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

Journal of psychopharmacology (Oxford), 2011-05, Vol.25 (5), p.685-697

2011

Volltextzugriff (PDF)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour-related pain

European journal of pain, 2016-10, Vol.20 (9), p.1513-1518

2016

Volltextzugriff (PDF)

Postural control during a transition task in haemophilic children, adolescents and young adults with haemophilic ankle arthropathy

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.667-674

2018

Volltextzugriff (PDF)

Tapentadol immediate release for moderate to severe acute post-surgery pain

Journal of opioid management, 2019-01, Vol.15 (1), p.51-67

2019

Volltextzugriff (PDF)

Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study

International clinical psychopharmacology, 2011-01, Vol.26 (1), p.25-34

2011

Volltextzugriff (PDF)

Comment on: "Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs"/Response

Drugs (New York, N.Y.), 2020-07, Vol.80 (11), p.1139-1143

2020

Volltextzugriff (PDF)

Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures

Neurology, 2010-03, Vol.74 (9), p.714-720

2010

Volltextzugriff (PDF)

The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets

Pharmacopsychiatry, 2009-07, Vol.42 (4), p.158-163

2009

Volltextzugriff (PDF)

The influence of hepatic impairment on the pharmacokinetics of paliperidone

International journal of clinical pharmacology and therapeutics, 2009-10, Vol.47 (10), p.606-616

2009

Volltextzugriff (PDF)

Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?

Journal of pain research, 2024-04, Vol.17, p.1327-1344

2024

Volltextzugriff (PDF)

Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain

Pain physician, 2014-07, Vol.17 (4), p.329-343

2014

Volltextzugriff (PDF)

1571P Cancer-related neuropathic pain (CRNP) in Europe: Impact of cancer stage on diagnosis and treatment of patients

Annals of oncology, 2022-09, Vol.33, p.S1265

2022

Volltextzugriff (PDF)

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial

Pain (Amsterdam), 2017-09, Vol.158 (9), p.1813-1824

2017

Volltextzugriff (PDF)

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

The American journal of psychiatry, 2003-06, Vol.160 (6), p.1125-1132

2003

Volltextzugriff (PDF)

Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study

British journal of psychiatry, 2005-09, Vol.187 (3), p.229-234

2005

Volltextzugriff (PDF)

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

International clinical psychopharmacology, 2010-09, Vol.25 (5), p.247-256

2010

Volltextzugriff (PDF)

The challenge of developing pain medications for children: therapeutic needs and future perspectives

Journal of pain research, 2019-05, Vol.12, p.1649-1664

2019

Volltextzugriff (PDF)

Outcomes of the Pediatric Development Plan of Tapentadol

Journal of pain research, 2021-01, Vol.14, p.249-261

2021

Volltextzugriff (PDF)

IDF2022-0829 Painful diabetic peripheral neuropathy: patients from four European countries report about its impact on their lives

Diabetes research and clinical practice, 2023-03, Vol.197, p.110526, Article 110526

2023

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders

The American journal of psychiatry, 2006-03, Vol.163 (3), p.402-410

2006

Volltextzugriff (PDF)

Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial

The American journal of psychiatry, 2005-05, Vol.162 (5), p.947-953

2005

Volltextzugriff (PDF)

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I)

Pain (Amsterdam), 2018-10, Vol.159 (10), p.2066-2075

2018

Volltextzugriff (PDF)

Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial

The American journal of psychiatry, 2005-10, Vol.162 (10), p.1888-1895

2005

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(154)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(84)
Humans
(58)
Female
(49)
Male
(49)
Adult
(37)
Psychiatry
(35)
Middle Aged
(34)
Biological And Medical Sciences
(33)
Medical Sciences
(32)
Double-Blind Method
(22)
Treatment Outcome
(22)
Aged
(21)
Neurosciences & Neurology
(21)
Adolescent
(20)
Clinical Neurology
(20)
Pharmacology. Drug Treatments
(19)
Neuropharmacology
(18)
Psychiatric Status Rating Scales
(18)
Psychology. Psychoanalysis. Psychiatry
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comment on: “Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs”

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour-related pain

Postural control during a transition task in haemophilic children, adolescents and young adults with haemophilic ankle arthropathy

Tapentadol immediate release for moderate to severe acute post-surgery pain

Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study

Comment on: "Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs"/Response

Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures

The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets

The influence of hepatic impairment on the pharmacokinetics of paliperidone

Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?

Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain

1571P Cancer-related neuropathic pain (CRNP) in Europe: Impact of cancer stage on diagnosis and treatment of patients

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

The challenge of developing pain medications for children: therapeutic needs and future perspectives

Outcomes of the Pediatric Development Plan of Tapentadol

IDF2022-0829 Painful diabetic peripheral neuropathy: patients from four European countries report about its impact on their lives

A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders

Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I)

Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial

Suchergebnisse filtern